Related Experiment Video
Updated: Apr 20, 2026
06:39
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
10.3K
Transplants in myelodysplastic syndromes
Katrin Wetzko1, Uwe Platzbecker1
1Medical Clinic 1, University Hospital "Carl-Gustav-Carus" at TUD, Fetscherstraße 74, 01307 Dresden, Germany.
Hematology/Oncology Clinics of North America
|December 3, 2014
Summary
Myelodysplastic syndromes are common in the elderly. While stem cell transplants offer a cure, hypomethylating agents provide a safer alternative for ineligible patients.
Area of Science:
- Hematology
- Oncology
Background:
- Myelodysplastic syndromes (MDS) are prevalent hematological disorders in the elderly.
- MDS incidence is rising due to de novo and secondary forms post-chemotherapy or radiotherapy.
- Allogeneic stem cell transplantation is a potential cure but limited by patient age and comorbidities.
Purpose of the Study:
- To review the therapeutic landscape for myelodysplastic syndromes.
- To discuss the role of reduced-intensity conditioning regimens and hypomethylating agents in MDS management.
Main Methods:
- Literature review of current therapeutic strategies for myelodysplastic syndromes.
- Analysis of treatment outcomes and toxicity profiles for various MDS therapies.
Main Results:
- Reduced-intensity conditioning regimens improve early tolerability of stem cell transplantation.
- Late effects of stem cell transplantation remain a significant challenge.
- Hypomethylating agents offer an alternative with a moderate toxicity profile.
Conclusions:
- Hypomethylating agents represent a viable therapeutic option for elderly MDS patients ineligible for stem cell transplantation.
- Further research is needed to optimize late-effect management after reduced-intensity conditioning regimens.
Related Concept Videos
01:22Bone Marrow Sampling and Transplants
2.8K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.8K
01:24Tissue Transplantation
1.3K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.3K